Implementation Guide CH VACD
2.0.0 - STU 2
Implementation Guide CH VACD
2.0.0 - STU 2
This page is part of the CH VACD (R4) (v2.0.0: STU 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
Summary
| Defining URL: | http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-laboratory-serology-vs |
| Version: | 2.0.0 |
| Name: | LaboratorySerologyImmunization |
| Title: | Laboratory Serology for Immunization |
| Status: | Active as of 2022-02-11 02:45:16+0100 |
| Definition: | Laboratory Serology for immunization |
| Publisher: | HL7 Switzerland |
| Source Resource: | XML / JSON / Turtle |
References
http://loinc.org| Code | Display |
| 22602-7 | Varicella zoster virus IgG Ab [Titer] in Serum |
| 22502-9 | Measles virus IgG Ab [Titer] in Serum |
| 41763-4 | Rubella virus IgG Ab [Titer] in Serum |
| 22313-1 | Hepatitis A virus IgG Ab [Units/volume] in SerumActive |
| 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum |
| 26061-2 | European tick borne encephalitis virus Ab [Titer] in Serum |
| 6589-6 | Yellow fever virus Ab [Titer] in Serum by Immunofluorescence |
| 58770-9 | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 94505-5 | SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 14128-3 | Rabies virus Ab [Titer] in Serum |
Additional Language Displays
| Code | Deutsch (Schweiz) (German (Switzerland), de) | English (United States) (English (United States), en) | French (Switzerland) (fr) | Italian (Switzerland) (it) | rm |
| 22602-7 | Varizellen-Zoster-Virus IgG Ab [Titer] in Serum | Varicella zoster virus IgG Ab [Titer] in Serum | Anticorps IgG du virus varicelle-zona [titre] dans le sérum | virus varicella-zoster Ab IgG [titolo] in siero | Varizellen-Zoster-Virus IgG Ab [Titer] in Serum |
| 22502-9 | Masern-Virus IgG Ab [Titer] in Serum | Measles virus IgG Ab [Titer] in Serum | Anticorps IgG du virus de la rougeole [titre] dans le sérum | virus del morbillo Ab IgG [titolo] in siero | Masern-Virus IgG Ab [Titer] in Serum |
| 41763-4 | Röteln-Virus IgG Ab [Titer] in Serum | Rubella virus IgG Ab [Titer] in Serum | Anticorps IgG du virus de la rubéole [titre] dans le sérum | virus della rosolia Ab IgG [titolo] in siero | Röteln-Virus IgG Ab [Titer] in Serum |
| 22313-1 | Hepatitis-A-Virus IgG Ab [Einheiten/Volumen] in SerumAktiv | Hepatitis A virus IgG Ab [Units/volume] in SerumActive | Anticorps IgG du virus de l'hépatite A [unités/volume] dans le sérum | virus dell'epatite A Ab IgG [unità/volume] in siero attivo | Hepatitis-A-Virus IgG Ab [Einheiten/Volumen] in SerumAktiv |
| 16935-9 | Hepatitis-B-Virus-Oberfläche Ab [Einheiten/Volumen] in Serum | Hepatitis B virus surface Ab [Units/volume] in Serum | Anticorps surface du virus de l'hépatite B [unités/volume] dans le sérum | virus dell'epatite B Ab di superficie [unità/volume] in siero | Hepatitis-B-Virus-Oberfläche Ab [Einheiten/Volumen] in Serum |
| 26061-2 | Europäischer Zeckenenzephalitis-Virus Ab [Titer] in Serum | European tick borne encephalitis virus Ab [Titer] in Serum | Anticorps du virus de l'encéphalite à tiques européennes [titre] dans le sérum | virus della meningoencefalite da zecche europea Ab [titolo] in siero | Europäischer Zeckenenzephalitis-Virus Ab [Titer] in Serum |
| 6589-6 | Gelbfieber-Virus Ab [Titer] in Serum durch Immunfluoreszenz | Yellow fever virus Ab [Titer] in Serum by Immunofluorescence | Anticorps du virus de la fièvre jaune [titre] dans le sérum par immunofluorescence | virus della febbre gialla Ab [titolo] in siero mediante immunofluorescenza | Gelbfieber-Virus Ab [Titer] in Serum durch Immunfluoreszenz |
| 58770-9 | Clostridium tetani Toxoid IgG Ab [Einheiten/Volumen] in Serum durch Immunfluoreszenz | Clostridium tetani toxoid IgG Ab [Units/volume] in Serum by Immunofluorescence | Anticorps IgG de la toxine du Clostridium tetani [unités/volume] dans le sérum par immunofluorescence | tossoide di Clostridium tetani Ab IgG [unità/volume] in siero mediante immunofluorescenza | Clostridium tetani Toxoid IgG Ab [Einheiten/Volumen] in Serum durch Immunfluoreszenz |
| 94505-5 | SARS-CoV-2 (COVID-19) IgG Ab [Einheiten/Volumen] in Serum oder Plasma durch Immunoassay | SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | Anticorps IgG du SARS-CoV-2 (COVID-19) [unités/volume] dans le sérum ou le plasma par immunoanalyse | SARS-CoV-2 (COVID-19) Ab IgG [unità/volume] in siero o plasma mediante immunodosaggio | SARS-CoV-2 (COVID-19) IgG Ab [Einheiten/Volumen] in Serum oder Plasma durch Immunoassay |
| 14128-3 | Tollwut-Virus Ab [Titer] im Serum | Rabies virus Ab [Titer] in Serum | Anticorps du virus de la rage [titre] dans le sérum | virus della rabbia Ab [titolo] in siero | Tollwut-Virus Ab [Titer] im Serum |
This value set contains 10 concepts
Expansion based on Loinc v2.71
All codes in this table are from the system http://loinc.org
| Code | Display |
| 22602-7 | Varizellen-Zoster-Virus IgG Ab [Titer] in Serum |
| 22502-9 | Masern-Virus IgG Ab [Titer] in Serum |
| 41763-4 | Röteln-Virus IgG Ab [Titer] in Serum |
| 22313-1 | Hepatitis-A-Virus IgG Ab [Einheiten/Volumen] in SerumAktiv |
| 16935-9 | Hepatitis-B-Virus-Oberfläche Ab [Einheiten/Volumen] in Serum |
| 26061-2 | Europäischer Zeckenenzephalitis-Virus Ab [Titer] in Serum |
| 6589-6 | Gelbfieber-Virus Ab [Titer] in Serum durch Immunfluoreszenz |
| 58770-9 | Clostridium tetani Toxoid IgG Ab [Einheiten/Volumen] in Serum durch Immunfluoreszenz |
| 94505-5 | SARS-CoV-2 (COVID-19) IgG Ab [Einheiten/Volumen] in Serum oder Plasma durch Immunoassay |
| 14128-3 | Tollwut-Virus Ab [Titer] im Serum |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |